Wide Ranks

KLTO

Klotho Neurosciences, Inc.

0.3400

Top Statistics
Market Cap 7 M Forward PE 0.0000 Revenue Growth 0.00 %
Current Ratio 1.11 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 845336 Total Cash Per Share 0.0400 Total Debt 3 M
Total Debt To Equity Current Ratio 1.11 Book Value Per Share 0.0010
All Measures
Short Ratio 34.00 % Message Board Id finmb_36437530 Shares Short Prior Month 106881
City Omaha Uuid c58a2b32-b271-3924-a993-e2bf3c3d98be Previous Close 0.3283
First Trade Date Epoch Utc 1 B Book Value 0.0010 Beta 0.0560
Total Debt 3 M Volume 37800 Price To Book 340.00
Fifty Two Week Low 0.2600 Total Cash Per Share 0.0400 Shares Short Previous Month Date 1 B
Max Age 86400 Sand P52 Week Change 0.3133 Net Income To Common -1394269
Ask 0.3546 Implied Shares Outstanding 21 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 195060 Average Volume10days 195060
Total Cash 845336 Next Fiscal Year End 1 B Held Percent Insiders 0.5628
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 0.3283 Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000
Fifty Day Average 0.5154 Open 0.3307 Free Cashflow -168167
State NE Dividend Yield 0.00 % Return On Assets -0.2357
Time Zone Short Name EST Day Low 0.3210 Address1 13576 Walnut Street
Shares Outstanding 21 M Price Hint 4 Target High Price 0.0000
Website https://www.klothoneuro.com 52 Week Change -0.9682 Average Volume 242898
Recommendation Key none Forward Eps 0.0000 Compensation As Of Epoch Date 1 B
Quick Ratio 94.10 % Is_sp_500 False Regular Market Day High 0.3583
Profit Margins 0.00 % Fifty Two Week High 13.10 Day High 0.3583
Shares Short 142280 Regular Market Open 0.3307 Industry Key biotechnology
Bid 0.4600 Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0067 Operating Cashflow -1134886 Currency USD
Time Zone Full Name America/New_York Market Cap 7 M Is_nasdaq_100 False
Zip 68144 Quote Type EQUITY Industry Biotechnology
Long Name Klotho Neurosciences, Inc. Regular Market Day Low 0.3210 Held Percent Institutions 0.1142
Current Price 0.3400 Address2 Suite A Financial Currency USD
Current Ratio 1.11 Industry Disp Biotechnology Country United States
Float Shares 9 M Two Hundred Day Average 4.30 Enterprise Value 10 M
Forward PE 0.0000 Regular Market Volume 37800 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics.

Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.

The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases.

The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024.

Klotho Neurosciences, Inc. is based in Omaha, Nebraska.